ATGL deficiency induces pulmonary neoplasia in an animal model [62], and lung cancer cells depleted of ATGL migrate faster by activation of pro‐oncogenic signaling via SRC kinase and increased levels of bioactive lipids [63]. This evidence concerns the gene PNPLA2 and lung carcinoma.